Navigation Links
Anesthesiologists Use Caldolor® To Provide Preemptive Pain Control for Surgical Patients at U.S. Medical Centers
Date:3/2/2011

ing surgery. Reduction in opioid use could reduce opioid-related side effects such as sedation, nausea, vomiting, cognitive impairment and respiratory depression.

William Weisberg, D.O., anesthesiologist and medical director at the Surgery Center at Coral Springs in Coral Springs, Florida, has also seen improved post-surgical outcomes by administering Caldolor to patients at induction of anesthesia. "Initiating Caldolor's analgesic and anti-inflammatory properties prior to surgery minimizes the cascade of pain and inflammation, which is resulting in improved pain relief in the 24 hour period following surgery," said Dr. Weisberg. "This method of addressing pain before it occurs coupled with Caldolor's ability to achieve better pain control than opioids alone translates to less patient pain and a lower requirement for opioids. Our use of opioid rescue in the PACU (post-anesthesia care unit) has decreased, and incorporation of Caldolor into our multi-modal pain management model has led to increased patient satisfaction."

In clinical trials, Caldolor has demonstrated pain relief above and beyond that which was provided by opioids alone, while also reducing opioid use. A published study, entitled "A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial of Intravenous-Ibuprofen (IV-Ibuprofen) for Treatment of Pain in Post-Operative Orthopedic Adult Patients," appeared in the August 2010 edition of the peer-reviewed journal Pain Medicine, and concluded that dosing Caldolor at induction of analgesia as well as post-operatively is effective in treating pain and reducing morphine use in adult patients. This study provides safety and efficacy data supporting use of Caldolor in surgical patients not only during recovery, but also when administered prior to surgery.

"In the practice of acute pain medicine, reducing reliance on opioids is a strategic imperative," said Jonathan S. Jahr, M.D., Co-Editor of The Essence of Analgesia and Analg
'/>"/>

SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Thermogard XP(TM) Studies to Be Presented at American Society of Anesthesiologists Annual Meeting
2. AcelRx Programs to be Featured in Oral Presentations at the American Society of Anesthesiologists 2009 Annual Meeting
3. Over 20 New Clinical Studies Presented on Masimo Noninvasive Patient Monitoring Technologies at the American Society of Anesthesiologists Annual Meeting
4. Pre and Post-Operative Use of Caldolor® (Ibuprofen) Injection Significantly Reduces Pain and Opioid Use in Newly Published Study
5. Caldolor® (ibuprofen) Injection Gaining Approval on Formulary at U.S. Medical Centers
6. Newly Published Data Demonstrates Caldolor® Significantly Reduces Pain and Morphine Use in Post-Operative Patients
7. Caldolor® Rapid Infusion Shown to be Safe and Well Tolerated in Newly Published Clinical Study
8. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
11. Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)...  Astellas today announced topline results from the ... safety of intravenous (IV) and oral isavuconazole, commercially ... adults with candidemia and other invasive Candida ... the trial did not meet its primary endpoint ... patients at the end of IV therapy compared ...
(Date:7/29/2015)... 29, 2015  Unilife Corporation ("Unilife" or the "Company") ... manufacturer and supplier of injectable drug delivery systems, today ... provides the Company with flexibility and control to support ... signed an equity purchase agreement for up to $45 ... Chicago -based institutional investor, which provides ...
(Date:7/29/2015)... , July 29, 2015  According to data ... Services, the 2016 average monthly Medicare Part D premium ... far lower than was originally projected, the Pharmaceutical Care ... D program continues to be a bright spot in ... choices in each region and using cutting edge, cost-saving ...
Breaking Medicine Technology:Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 2Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 3Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 4Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 5Unilife Announces Multifaceted Financing Strategy 2Unilife Announces Multifaceted Financing Strategy 3Unilife Announces Multifaceted Financing Strategy 4Unilife Announces Multifaceted Financing Strategy 5
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... Ross ... (UCF) College of Medicine as Assistant Professor of Plastic Surgery. This is Dr. ... Clevens has worked closely with the university, developing a strong presence and a valuable ...
(Date:7/30/2015)... ... July 30, 2015 , ... Using the latest online digital technologies, happiness expert ... ways to prevent and manage major depression. , “Suicide is 100% preventable. The problem ... through the cracks and die needlessly everyday,” says Walker. “I’m out to end suicide. ...
(Date:7/30/2015)... ... July 30, 2015 , ... Between 2012 and 2014 HIV infection rates rose ... on June 17th. Those untreated heroin use disorders share their needles and spread ... dirty needles throughout the community. Ultimately Florida’s HIV infection rates have bolstered to 23 ...
(Date:7/30/2015)... ... July 30, 2015 , ... The American Association ... Rosenberg’s announcement of the reinstitution of National Prescription Drug Take-Back Days. The 10th ... 10:00 AM to 2:00 PM local time. On the 26th, the DEA, with ...
(Date:7/30/2015)... ... July 30, 2015 , ... InventHelp, a leading inventor service ... personal-care device that makes it easy to apply lotion or medication to a hard-to-reach ... assistance when applying lotion or medication to the back, and provides thorough coverage. The ...
Breaking Medicine News(10 mins):Health News:Leading Melbourne Facial Plastic Surgeon Reappointed by UCF 2Health News:Leading Melbourne Facial Plastic Surgeon Reappointed by UCF 3Health News:Happiness Expert Develops Pioneering Online Tools for Sufferers of Major Depression, and Who may be Suicidal 2Health News:Happiness Expert Develops Pioneering Online Tools for Sufferers of Major Depression, and Who may be Suicidal 3Health News:HIV Rates Rise in S. Florida, Harbor Village Comments on Health News Florida's Recent Article 2Health News:HIV Rates Rise in S. Florida, Harbor Village Comments on Health News Florida's Recent Article 3Health News:AAPCC Supports National Prescription Drug Take-Back Day 2Health News:AAPCC Supports National Prescription Drug Take-Back Day 3Health News:InventHelp® Client Patents “My Back Buddy” – Device Could Apply Lotion to Hard-to-Reach Areas Easily 2
... ROCHESTER, Minn. A new study led by researchers ... institutions has found that patients with non-Hodgkin,s lymphoma who ... diagnosis had poorer overall survival, compared to patients who ... after accounting for clinical and demographic factors, and also ...
... known by its brand name Celebrex, can help prevent the ... and small intestine of children with an inheritable genetic disease ... but devastating disease, polyps begin forming in patients as young ... or even thousands. The disease carries a 100-percent lifetime ...
... males tying the knot with younger females, study found , THURSDAY, ... nine years their junior could be upping their odds of dying ... younger guy raises a woman,s risk of death by 20 percent, ... Demography . , Not that marrying much older men is ...
... ... unveil the Center for Biotechnology Education on Thursday, May 13, at its fifth ... County campus, 9601 Medical Center Drive in Rockville. , ... (PRWEB) May 13, 2010 -- The Johns Hopkins University’s Zanvyl ...
... ... owners have been scratching their heads trying to understand the new EPA “Lead-Based Paint ... , ... 13, 2010 -- MT2, LLC of Arvada, CO is providing eco-protective green technology to ...
... The Wistar Institute offer a new explanation for the persistent ... why melanoma remains the deadliest form of skin cancer. The ... melanoma cells behave like both conventional tumor cells and cancer ... issue of the journal Cell thatcontrary to other ...
Cached Medicine News:Health News:Lifestyle factors significantly impact survival of non-Hodgkin's lymphoma patients, study finds 2Health News:Lifestyle factors significantly impact survival of non-Hodgkin's lymphoma patients, study finds 3Health News:Lifestyle factors significantly impact survival of non-Hodgkin's lymphoma patients, study finds 4Health News:Women Who Marry Younger Men May Die Earlier 2Health News:Johns Hopkins to Unveil Center for Biotechnology Education 2Health News:Johns Hopkins to Unveil Center for Biotechnology Education 3Health News:Contractors Discover Relief from New EPA LBP RRP Rule 2Health News:Contractors Discover Relief from New EPA LBP RRP Rule 3Health News:Wistar scientists explain the persistence of melanoma through 'dynamic stemness' 2Health News:Wistar scientists explain the persistence of melanoma through 'dynamic stemness' 3
An environmentally-safe, CN-free lytic reagent designed for use on the Abbott CELL-DYN® 1800 three-part differential hematology analyzer....
... Retics is a 5-part differential control that ... Abbott CELL-DYN 3200, 3500, 3700 and 4000 ... nucleated red blood cells that can be ... The assay contains automated and manual reticulocyte ...
... hematology control for the Abbott CELL-DYN 3000, ... for the five-part white cell differential, as ... CELL-DYN 1600 and 1700. Open-vial stability is ... days. Para 12 Plus is packaged in ...
The technology in the LATITUDE system allows your doctor to get the same data from your device whether you are at home or in your doctor's office. This information transfer happens automatically....
Medicine Products: